A follow-up study of prescribing for people with learning disabilities previously in National Health Service care in Leicestershire, England.

Branford (1997) tracked psychotropic prescriptions for adults with intellectual disability. All had moved from NHS hospitals to community homes in Leicestershire, England. The team compared drug use before and after the move.

Doctors reviewed each medication, yet most psychotropic levels stayed the same or rose. Only antidepressant use changed a lot.

Community placement did not cut psychotropic drug use. Most people kept the same pills, and some got more. Drug reviews alone were not enough to lower doses.

The move helped people leave institutions, but it did not solve over-medication.

Bhaumik et al. (2009) extends this picture. They show aggression dropped sharply six months after the same kind of move. So behaviour can improve even while pill counts stay high.

Cerutti et al. (2004) looked at 2,344 US adults 17 months later. Six in ten received two or more psychoactive drugs at once. The problem is bigger than one English county.

Fahmie et al. (2013) adds a hopeful note. In a New York survey of 4,069 adults, half of antipsychotic orders now target real psychiatric diagnoses, not just behaviour control. Practice is slowly shifting toward better reasons to medicate.

If you help adults with ID move to community homes, do not assume drug reviews will cut psychotropics. Plan extra checks: ask for diagnosis, behaviour data, and taper trials. Pair the move with behaviour support, as Bhaumik et al. (2009) shows aggression can drop without more meds. Use the Cerutti et al. (2004) and Fahmie et al. (2013) numbers as benchmarks when you audit prescribing in your own agency.